Methylnaltrexone and gastrointestinal perforation.
Mackey
Ann Corken
AC
Green
Lanh
L
Greene
Patty
P
Avigan
Mark
M
D000701:Analgesics, Opioid / Q000009:adverse effects / Q000037:antagonists & inhibitors; D006801:Humans; D007416:Intestinal Perforation / Q000139:chemically induced* / Q000453:epidemiology; D009271:Naltrexone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D010166:Palliative Care; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D014481:United States
D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009271:Naltrexone